Search
for
Sort by
Research 931–960 of 1000+
- Actualités du SOPK
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- DRUGS AND DEVICES IN PREVENTION AND TREATMENT OF CHEMOTHERAPY-INDUCED ALOPECIA: WHEN AND HOW SHOULD BE EMPLOYED
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Frontal fibrosing alopecia: A multicenter review of 355 patients
- Adipose tissue-derived stromal vascular fraction in regenerative medicine: a brief review on biology and translation
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Severe cutaneous adverse reactions to drugs
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- ATP-dependent chromatin remodeling during mammalian development
- Erectile Dysfunction in Young Men—A Review of the Prevalence and Risk Factors
- Endocrinology of Transgender Medicine
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- Physiologic skin changes in pregnancy
- Topical minoxidil in early male pattern baldness
- Obesity and the skin
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Cutaneous reactions to recombinant cytokine therapy
- Nutrition and Hair
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- DRUG‐ASSOCIATED ALOPECIA
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Menopause and aging, quality of life and sexuality
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Minoxidil therapy in children with severe hypertension
- Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: A randomized clinical trial
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome